Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chiron Negotiating Fluvirin Distribution Agreements For 2005 Flu Season

Executive Summary

Chiron is confident it will reach distribution agreements for the influenza vaccine Fluvirin for the 2005-2006 season, CEO Howard Pien said

You may also be interested in...



FDA Relaxes Restrictions on Live Vaccine Processing

Manufacturers of live vaccines such as those for influenza will soon be able to rely solely on process controls and, where necessary, process containment, to prevent cross-contamination of live vaccine organisms, under a recent direct final rule by FDA

FDA Relaxes Restrictions on Live Vaccine Processing

Manufacturers of live vaccines such as those for influenza will soon be able to rely solely on process controls and, where necessary, process containment, to prevent cross-contamination of live vaccine organisms, under a recent direct final rule by FDA

Pediatric Flu Vaccine Formulation Should Be Developed, Advisory Cmte. Says

A pediatric flu vaccine containing two influenza B strains should be developed, members of the FDA's Vaccines & Related Biological Products Advisory Committee recommended

Related Content

Topics

UsernamePublicRestriction

Register

MT101489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel